@nomadic_m:Closed out two put options today, expired worthless, generating additional premium income to bolster my core portfolio: $NVDX1 20250103 13.5 PUT$  $CLSK 20250103 10.0 PUT$   This strategic sale of put options has yielded a tidy profit, providing a supplemental source of capital to reinforce my core holdings.

@nomadic_m:$WisdomTree Japan Hedged Equity Fund(DXJ)$ I opportunistically entered DXJ during a brief downturn, and it has since become a quietly successful position. With a profit/loss of nearly 20%, this Japanese ETF has proven to be a valuable component of my diversified portfolio, providing a hedge against broader market volatility.

@nomadic_m:$Eli Lilly(LLY)$ is experiencing a notable correction today, driven by disappointing Q4 sales guidance. The company's expected sales of $13.5B fell short of consensus estimates ($14B), with underwhelming performances from Zepbound (obesity) and Mounjaro (diabetes). I've learned to recalibrate my perspective on such events. Rather than succumbing to fear, I recognize opportunities to buy the dip as a prudent long-term strategy. Notably, LLY serves as a strategic diversification component in my portfolio, providing a relatively stable hedge against the volatility inherent in my technology and cryptocurrency holdings. This allocation helps balance risk and potential returns, underscoring the importance of thoughtful portfolio construction.

@nomadic_m:Closed out $TSLL 20250124 23.2 PUT$ for a 100% profit, marking my highest return since initiating options trading. This successful trade validates my risk management strategy, which I continually refine to strike an optimal balance between returns and exposure. Grateful for the technical expertise of @Barcode , whose insights have significantly enhanced my trading acumen. Appreciation also goes to @SPACE ROCKET & @Happiness. for their ongoing support and encouragement. $Tesla Motors(TSLA)$  

@nomadic_m:Kudos to @InverseCramer today for the insightful tip. I decided to proactively close out my $SOUN 20250131 13.0 PUT$  position instead of letting it expire worthless. By buying back the put, I sacrificed 13% of the premium I initially sold it for, plus broker fee. However, this strategic move allowed me to accumulate 1 of 7 trades towards earning Tiger Coins, while also implementing a risk management technique. More importantly, it enabled me to prioritize family time, ensuring I'm fully present for my kid's music class & Zumba session on Saturday morning. Profit is nothing if one can't prioritize what truly matters. By making conscious trading decis

@nomadic_m:The recent market volatility, triggered by Trump tariffs and DeepSeek's announcements, has reinforced the importance of risk management in trading.  I initiated a sell put in $Semiconductor Bull 3X Shares(SOXL)$ with a strike price of $26.50, approximately 20-30% below the market price. However, as $SOXL oscillated wildly, my paper loss peaked at 1200%, rendering the collected premium negligible. To mitigate potential losses, I employed a wait-and-see approach, allowing time decay to work in my favor. As expiry approached, SOXL traded between $26.25 and $26.50 (so close, yet so far!). Finally decided to roll the position out for two weeks, adjusting the strike price downward to avoid assignment. *Key Takeaways* 1. *Risk ma

@nomadic_m:$Coinbase Global, Inc.(COIN)$ 's Q4 earnings report exceeded expectations, but its stock price dropped 7% after an initial 8% surge. I opened $CONL 20250221 34.0 PUT$, betting that the drop is just profit-taking and consolidation. The trade thesis is based on Coinbase's strong fundamentals and growth prospects. Now, it's time to let the trade play out. Fingers crossed for a strong rebound in the week ahead.

@nomadic_m:Rotating into$Alibaba(BABA)$ to hedge my US asset exposure. The recent pullback in US markets has led me to rebalance my portfolio and allocate funds to a high-growth, undervalued asset like Alibaba. The company's diversified ecosystem, comprising e-commerce, cloud computing, and digital payments, provides a compelling growth narrative. Furthermore, Alibaba's exposure to the burgeoning Chinese consumer market and its expanding presence in Southeast Asia offer a lucrative growth trajectory.

@nomadic_m:This week, I've been loading up on$Global X Nasdaq 100 Covered Call ETF(QYLD)$ , a strategic addition to my portfolio. I prefer QYLD over other Nasdaq-tracking ETFs due to its historically stable price action, courtesy of its covered call strategy. While QYLD may not offer the same growth potential as its unhedged counterparts, it more than makes up for it with consistent monthly dividend distributions. This steady income stream is ideal for reinvesting into my satellite portfolio, providing a regular influx of capital to optimize my overall portfolio performance. QYLD's unique blend of stability and income generation makes it an attractive holding for investors seeking to balance risk and reward. As a trader, I'm always on the lookout for op

@nomadic_m:$Stryker(SYK)$ 's diversified portfolio, strong brand recognition, and history of innovation make it a relatively resilient company in the face of economic downturns. Additionally, the demand for medical devices, particularly in the orthopedic and spinal care markets, tends to be less cyclical and more stable. Overall, Stryker is a solid company with a strong track record of financial performance and innovation. While it's not immune to market fluctuations, it's a relatively recession-resistant stock that can provide a stable foundation for a diversified portfolio.

@nomadic_m:As a novice investor, I recently bought shares of $Eli Lilly(LLY)$ at what I believe was the bottom, as part of my diversification strategy to mitigate tariff impact. I chose Eli Lilly for its strong fundamentals, including a robust pipeline of innovative drugs, such as its popular diabetes and obesity treatments. By investing in Eli Lilly, I aim to reduce my reliance on other sectors and benefit from the company's relatively lower exposure to tariffs, as pharmaceuticals are essential products. I plan to monitor tariff developments, track Eli Lilly's performance, and rebalance my portfolio as needed to maintain an optimal asset allocation and minimize risk.

@nomadic_m:Today's market sell-off, triggered by escalating tariff tensions, has been severe. However, my long-standing position $iShares 20+ Year Treasury Bond ETF(TLT)$ has demonstrated resilience, maintaining a modest gain. As a strategic investor, I've been auto-investing in TLT for over a year, anticipating a rally in response to potential interest rate cuts. Nevertheless, despite this lengthy holding period, my average entry price remains above current market levels. While acknowledging the importance of a long-term perspective, I'm underwhelmed by the prospect of merely breaking even after a year. In my view, a satisfactory trade should generate a minimum annual return of 10%. What am I missing here?

@nomadic_m:Cashed in on some profits from my $Wal-Mart(WMT)$ position. Specifically, sold half of my shares the day after Liberation Day, driven by concerns about the potential impact of Trump's tariffs on the company's bottom line. Given Walmart's significant sourcing from China, I anticipated that the tariffs would hit them hard, so I decided to lock in some gains and reduce my exposure. And you know what? I feel liberated - like I've taken control of my trades and made a smart decision.

@nomadic_m:$Eli Lilly(LLY)$  's experimental pill orforglipron showed promising results in diabetes and weight loss trials, causing the stock to surge 16%. Despite market volatility from tariffs, this dip presents a strategic buying opportunity. Investors can capitalize on the stock's long-term growth potential.

@nomadic_m:Captured $Eli Lilly(LLY)$  volatility anomaly post-earnings with a targeted sell put strategy. The 11% drop was an overreaction to weak Q1 2025 results and EPS miss. I identified a high-probability rebound opportunity and executed a short-dated sell put contract at the $800 strike $LLY 20250502 800.0 PUT$ . Managed risk effectively, and the trade played out as expected. Collected the full premium at expiry. Solid demo trade that reinforced my strategy.

@nomadic_m:I'm strategically accumulating $SPDR Gold Shares(GLD)$ as a tactical buy, opting for a more liquid and diversified approach over physical gold jewelry. I have no target entry price; my strategy is to buy on every red day and hold off on every green day.

@nomadic_m:I'm prepping to exit my entire $SUPER MICRO COMPUTER INC(SMCI)$ position, prioritizing risk management over potential upside. Discipline over attachment – time to redeploy capital into higher-conviction plays

@nomadic_m:$MELI 20250530 2630.0 CALL$ $500+ profit per week yo! if only this is my main account 🤣

@nomadic_m:Just rode the $NVIDIA Corp(NVDA)$ wave post-earnings, sold a call on $Navitas Semiconductor Corp(NVTS)$ - seems like a strategic move given the current market dynamics $NVTS 20250718 13.0 CALL$   NVIDIA and Navitas Semiconductor have partnered to develop an 800V HVDC architecture for data centers, leveraging Navitas' GaN and SiC power semiconductor technologies to improve efficiency, reliability, and scalability for AI infrastructure.